Noticing a slow drift in recall or sharper mental fatigue can be unsettling. For many older adults, that quiet erosion of memory and executive function tracks alongside changes in how brain cells produce and use energy. A 2026 review of creatine and brain aging took a careful look at whether a supplement long tied to physical performance might have a role to play in that energy story — not as a magic bullet, but as a potential way to shore up a cellular fuel system that falters with age.
The idea isn’t new, but the evidence is patchy enough that the review’s authors had to sift through contradictions: some studies showing clear cognitive bumps, others flat results, and a handful pointing toward bigger questions about dose and timing. What follows isn’t a prescription. It’s a look at what the data says, what it doesn’t, and why the dose you take matters more than most people realize.
The Brain’s Energy Crisis in Aging
A healthy brain burns through adenosine triphosphate (ATP) at a staggering rate, especially when you’re concentrating, solving a problem, or pulling up a memory. The phosphocreatine (PCr) system acts as a rapid-response energy buffer — converting ADP back to ATP almost instantly, giving you a few seconds of high-level cognitive fuel. In aging and conditions like Alzheimer’s disease, that system gets less efficient. Mitochondrial function sputters, oxidative stress piles up, and brain cells struggle to meet energy demands.
A Baptist Health report describes how reduced brain energy metabolism is a hallmark of Alzheimer’s, not just a bystander. The thinking, then, is that boosting phosphocreatine stores with creatine supplementation might nudge the system back toward its usual balance. No one claims this reverses dementia. But the hypothesis — supported by a Healthspan discussion of creatine’s brain energy mechanism — hangs on a plausible thread: if your brain’s fuel reserve runs low, topping it up might matter.
Key Studies on Creatine and Cognitive Function in Older Adults
The research doesn’t speak with one voice. In 2007, McMorris and colleagues gave older adults 20 grams of creatine daily for just seven days and reported improvements in memory tasks — a quick, sharp signal that the aging brain might respond to a creatine load. A few years earlier, Watanabe et al. (2002) used 8 grams per day for five days and saw better performance on serial calculation, a task that taxes working memory and speed. Both studies were small, short-term, and nowhere near proof that creatine can roll back cognitive decline, but they lit a fire under the field.
Vegetarians, who tend to have lower baseline creatine stores, have shown even more pronounced responses. Rae et al. (2003) and Benton & Donohoe (2011) each found cognitive improvements in vegetarian participants after supplementation. That’s a wrinkle worth noticing: it might mean that people whose diets already supply steady creatine from meat and fish have less to gain, while those starting from a deficit see bigger swings.
But then there’s the other side. Rawson et al. (2008) used a dose of only 0.03 grams per kilogram of body weight daily — roughly 2 grams for a 70-kilogram person — over six weeks and found no cognitive benefit at all. A handful of null results like that one underscore how much dose matters. The Forbes et al. (2022) review pulled together the accumulating evidence and suggested a neuroprotective potential worth exploring, not a settled fact. And a striking study by Bender & Klopstock (2016) showed creatine slowed brain atrophy in Huntington’s disease. Extrapolating that to normal aging requires caution — Huntington’s is a different beast — but it adds weight to the idea that creatine can cross the blood-brain barrier and influence brain structure.
Why the Dose and Duration Matter
Getting creatine into the brain isn’t as straightforward as swallowing a pill. The blood-brain barrier is stingy with what it lets through, so reaching levels that affect cognition often takes higher doses or longer timelines than what’s used for muscle growth. A standard loading protocol — 20 grams a day, split into four 5-gram doses, for five to seven days — saturates muscle and brain phosphocreatine stores within a week. Without loading, taking just 5 grams daily, it can take two to three weeks to reach the same saturation. That difference alone helps explain why short-term studies at low doses might come up empty.
The Rawson et al. (2008) null result at roughly 2 grams a day is a clear illustration: subtherapeutic doses can simply miss the point. By contrast, the pilot Alzheimer’s study reported by Baptist Health used 20 grams daily — far higher than the typical 5-gram athletic dose — and observed tolerability while aiming to boost brain creatine levels enough to matter. Research paradigms vary wildly: single-dose spins, week-long sprints, six-week trials. Each answers a different question, and none yet tells us what a year or more of consistent use might do for an aging brain. The long-term picture is still being painted.
Safety Profile and Addressing Common Concerns
A widespread worry about kidney damage still follows creatine around, mostly left over from early case reports that didn’t hold up in larger data. The International Society of Sports Nutrition position stand by Kreider et al. (2017) concluded that creatine monohydrate is safe for long-term use in healthy people. That’s one of the more thorough safety reviews in the supplement world.
Stomach complaints do pop up in some studies — bloating, cramps — but the Baptist Health article notes an intriguing possibility: in elderly participants, a nocebo effect might account for some of the gastrointestinal distress, not the creatine itself. In the Alzheimer’s pilot, even at 20 grams a day, the supplement was well-tolerated overall. Still, individual sensitivities aren’t rare. For anyone with reduced kidney function or who takes medications that affect renal health, a conversation with a doctor isn’t optional — it’s the starting point. Safety data is strong, but it’s not unconditional.
Practical Considerations for Older Adults
If someone decides to explore creatine as a possible cognitive tool, form matters. The studies that showed cognitive improvements — McMorris et al., Watanabe et al., and the vegetarian trials — all used creatine monohydrate, the simple, cheap, and exhaustively researched version. It’s easy to get distracted by salts, esters, or fancy blends, but none of those have a comparable footprint in cognitive aging research. A pure powder without fillers keeps things straightforward. And because this use case sits outside the usual athletic context, it’s worth framing the conversation not as “should I take this?” but “given my health profile, does this make any sense?” — a question only a physician can help answer.
Selecting a Creatine Supplement: Monohydrate as the Evidence-Backed Option
The studies that matter here — the ones probing memory and mental speed in older adults — all relied on creatine monohydrate, not the newer salt or ester variants. Those alternatives market themselves on better absorption or fewer side effects, but their track record in cognitive trials is thin. Sticking with a plain creatine monohydrate powder, the kind used in the bulk of the evidence, simply removes an unnecessary variable. Additives and proprietary blends rarely add clarity, and in a context where you’re trying to replicate study conditions as closely as safety allows, pure monohydrate is the most grounded choice.
Combining supplementation with exercise, decent sleep, and a nutrient-dense diet remains the base of any brain health effort. Creatine won’t replace that. It’s a potential extra tool — one that some older brains seem to use more readily than others, and one that deserves reality-checking against your own medical history.